Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings, has agreed to invest approximately $27.2m in Inogen, ...

INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.

On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai, and announced ...

Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating on January 14.Invest with Confidence: ...

Yuwell Medial and Inogen formalized a strategic investment and cooperation As one of the world's largest manufacturers of oxygen concentrators, Yuwell Medical is widely recognized for its strong R&D ...

More on INGN’s Robust Product Portfolio Inogen’s expanding product portfolio is a significant driver of its growth. It offers a range of oxygen concentrator solutions for both portable and ...

As one of the world's largest manufacturers of oxygen concentrators, Yuwell Medical is widely recognized for its strong R&D capabilities and advanced manufacturing capabilities. Inogen ...

Yuwell Medial and Inogen formalized a strategic investment and cooperation As one of the world's largest manufacturers of oxygen concentrators, Yuwell Medical is widely recognized for its strong R&D ...